BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22633270)

  • 1. Universal maternal cervical length screening during the second trimester: pros and cons of a strategy to identify women at risk of spontaneous preterm delivery.
    Parry S; Simhan H; Elovitz M; Iams J
    Am J Obstet Gynecol; 2012 Aug; 207(2):101-6. PubMed ID: 22633270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pros and cons of maternal cervical length screening to identify women at risk of spontaneous preterm delivery.
    Parry S; Elovitz MA
    Clin Obstet Gynecol; 2014 Sep; 57(3):537-46. PubMed ID: 24979358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?].
    Rozenberg P
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1337-1345. PubMed ID: 28166925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not transabdominal!
    Khalifeh A; Berghella V
    Am J Obstet Gynecol; 2016 Dec; 215(6):739-744.e1. PubMed ID: 27889000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis.
    Werner EF; Han CS; Pettker CM; Buhimschi CS; Copel JA; Funai EF; Thung SF
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):32-7. PubMed ID: 21157771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal cervical length screening in singleton gestations without a previous preterm birth: ten reasons why it should be implemented.
    Khalifeh A; Berghella V
    Am J Obstet Gynecol; 2016 May; 214(5):603.e1-5. PubMed ID: 26707072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short cervical length dilemma.
    Suhag A; Berghella V
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):241-54. PubMed ID: 26002164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.
    Alfirevic Z; Owen J; Carreras Moratonas E; Sharp AN; Szychowski JM; Goya M
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):146-51. PubMed ID: 22991337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW; Seto MTY; Ng EHY
    Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal cervical length screening for prediction and prevention of preterm birth.
    Berghella V
    Obstet Gynecol Surv; 2012 Oct; 67(10):653-8. PubMed ID: 23112072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
    Maerdan M; Shi C; Zhang X; Fan L
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvaginal cervical length scans to prevent prematurity in twins: a randomized controlled trial.
    Gordon MC; McKenna DS; Stewart TL; Howard BC; Foster KF; Higby K; Cypher RL; Barth WH
    Am J Obstet Gynecol; 2016 Feb; 214(2):277.e1-277.e7. PubMed ID: 26363481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transabdominal ultrasound is appropriate.
    Stamilio D; Carlson LM
    Am J Obstet Gynecol; 2016 Dec; 215(6):739-743.e1. PubMed ID: 27888999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the cost-effectiveness of universal cervical length screening: importance of progesterone efficacy.
    Jain S; Kilgore M; Edwards RK; Owen J
    Am J Obstet Gynecol; 2016 Jul; 215(1):101.e1-7. PubMed ID: 26821336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel developments on cervical length screening and progesterone for preventing preterm birth.
    Berghella V
    BJOG; 2009 Jan; 116(2):182-7. PubMed ID: 19076950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of universal screening for preterm delivery by mid-trimester cervical-length measurement.
    Souka AP; Papastefanou I; Pilalis A; Kassanos D; Papadopoulos G
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):396-401. PubMed ID: 29536576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.